Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy
Zhengpeng Zeng1, ShengYang He1, JunJuan Lu1
1a Center for Experimental Medical Research , the Third Xiangya Hospital of Central South University , Changsha , Hunan , P.R. China.
Abstract:
MicroRNAs and autophagy play important roles in chronic obstructive pulmonary disease (COPD). This study was designed to explore the role of microRNA-21 (miR-21) induced autophagy in COPD. Using the C57BL/6, miR-21-/- mice and human bronchial epithelial (16HBE) cell line, we found that in the lung tissues of mice, the level of autophagy in the COPD model group was significantly higher than that in the control group. However, compared to the COPD model, the level of autophagy was significantly lower in the miR-21-/- CSE+CS group. In the COPD model, miR-21 was overexpressed. Moreover, in human bronchial epithelial (16HBE) cells exposed to cigarette smoke extract (CSE), miR-21 expression was upregulated and autophagy was notably increased. In addition, pretreatment of 16HBE cells with miR-21 inhibitor significantly inhibited autophagy activity and decreased apoptosis, indicating that miR-21 is involved in CSE-induced autophagy and apoptosis. The results showed that miR-21 could increase autophagy and promote the apoptosis of 16HBE cells in COPD. This information contributes to our further understanding of COPD.
Insights
MicroRNA-21 (miR-21) promotes autophagy and apoptosis in chronic obstructive pulmonary disease (COPD). Inhibiting miR-21 reduces these effects, offering potential therapeutic targets for COPD.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Cellular Biology
Background:
- MicroRNAs and autophagy are implicated in chronic obstructive pulmonary disease (COPD) pathogenesis.
- Understanding the specific roles of microRNAs, like miR-21, in COPD is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of microRNA-21 (miR-21) in mediating autophagy in the context of COPD.
- To determine the impact of miR-21 on apoptosis in human bronchial epithelial cells exposed to cigarette smoke.
Main Methods:
- Utilized C57BL/6 mice and miR-21 knockout (miR-21-/-) mice models.
- Employed human bronchial epithelial (16HBE) cells exposed to cigarette smoke extract (CSE).
- Assessed autophagy levels and miR-21 expression in lung tissues and cell cultures; employed miR-21 inhibitors.
Main Results:
- COPD model mice exhibited significantly higher autophagy levels compared to controls.
- miR-21 knockout mice showed reduced autophagy compared to the COPD model.
- CSE exposure upregulated miR-21 expression and increased autophagy in 16HBE cells.
- miR-21 inhibition decreased CSE-induced autophagy and apoptosis in 16HBE cells.
Conclusions:
- MicroRNA-21 plays a significant role in inducing autophagy in COPD.
- miR-21 promotes apoptosis in human bronchial epithelial cells relevant to COPD.
- These findings highlight miR-21 as a potential therapeutic target for managing COPD progression.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

